Display options
Share it on
Full text links
American Society for Clinical Investigation Free PMC Article

J Clin Invest. 1993 Aug;92(2):1018-24. doi: 10.1172/JCI116607.

Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta.

The Journal of clinical investigation

J D Schuetz, S Kauma, P S Guzelian

Affiliations

  1. Department of Medicine, Medical College of Virginia, Richmond 23298-0267.

PMID: 8349787 PMCID: PMC294943 DOI: 10.1172/JCI116607
Free PMC Article

Abstract

Placenta and endometrium carry out steroidogenic biotransformation reactions such as 6-beta-hydroxylation of cortisol, a reaction characteristic of the dominant family of cytochromes P450 in human liver, CYP3A. To investigate the possible role in these extrahepatic tissues of the CYP3A microsomal hemoproteins, we analyzed placental and endometrial microsomes on Western blots developed with an anti-human CYP3A antibody. We found an immunoreactive 51,500 D protein that migrated between CYP3A3 (HLp) and CYP3A5 (HLp2) identical with CYP3A7 (HFLa). CYP3A7, a form found prominently in human fetal liver microsomes, was first isolated as a liver 16-alpha-dehydroepiandrosterone-sulfate hydroxylase. Northern blot analysis of total RNA isolated from placenta or from endometrium demonstrated a single band that cross-hybridized with a CYP3A7 cDNA. Amplification of the same RNA samples with the use of primers specific for CYP3A7, produced a 552-bp segment that had the predicted size and the same DNA sequence as does liver CYP3A7 cDNA. Hybridizable endometrial CYP3A7 mRNA was detected more frequently (six of seven samples) and in higher amounts (approximately 12-fold higher) in pregnant compared with nonpregnant women (4 of 12 samples). In addition, during the secretory phase of the menstrual cycle CYP3A7 expression was sixfold higher than in the one sample from the proliferative phase that had detectable CYP3A7 mRNA. Moreover, the amounts of placental and endometrial CYP3A7 mRNA and protein increased substantially from the first to the second trimester of pregnancy. We conclude that placenta and endometrium express the same P450 as is found in fetal liver. These tissues represent a previously unrecognized and quantitatively important site for 6-beta-hydroxylation and 16-alpha-hydroxylation of specific steroid precursors, possibly for protection of the fetus from the toxic effects of endogenous steroids and foreign substrates.

Cited by

References

  1. J Clin Invest. 1987 Oct;80(4):1017-22 - PubMed
  2. J Clin Endocrinol Metab. 1956 Jul;16(7):903-5 - PubMed
  3. Biochem Pharmacol. 1988 May 15;37(10):1947-53 - PubMed
  4. Arch Biochem Biophys. 1988 Jul;264(1):61-6 - PubMed
  5. Biochem Pharmacol. 1988 Aug 1;37(15):3053-5 - PubMed
  6. J Biol Chem. 1989 Jan 15;264(2):910-9 - PubMed
  7. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 - PubMed
  8. Obstet Gynecol. 1979 Jul;54(1):39-42 - PubMed
  9. Biochem Pharmacol. 1979 Mar 15;28(6):793-7 - PubMed
  10. Cancer Res. 1982 Dec;42(12):4875-917 - PubMed
  11. Pediatr Pharmacol (New York). 1982;2(3):199-207 - PubMed
  12. J Clin Endocrinol Metab. 1983 Apr;56(4):761-6 - PubMed
  13. Dev Pharmacol Ther. 1983;6(2):83-93 - PubMed
  14. Methods Enzymol. 1983;101:20-78 - PubMed
  15. Biol Res Pregnancy Perinatol. 1983;4(3):130-6 - PubMed
  16. J Biol Chem. 1984 Feb 10;259(3):2007-12 - PubMed
  17. Nucleic Acids Res. 1984 Jan 11;12(1 Pt 1):387-95 - PubMed
  18. Biochemistry. 1985 Apr 23;24(9):2171-8 - PubMed
  19. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6310-4 - PubMed
  20. J Biol Chem. 1985 Oct 25;260(24):13347-54 - PubMed
  21. J Biol Chem. 1986 Apr 15;261(11):5051-60 - PubMed
  22. Biochemistry. 1986 Mar 11;25(5):1124-33 - PubMed
  23. J Biol Chem. 1986 May 15;261(14):6264-71 - PubMed
  24. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5311-5 - PubMed
  25. Mol Pharmacol. 1986 Sep;30(3):287-95 - PubMed
  26. Gynecol Obstet Invest. 1986;22(2):64-72 - PubMed
  27. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8064-8 - PubMed
  28. Am J Obstet Gynecol. 1986 Dec;155(6):1170-5 - PubMed
  29. Biochem Pharmacol. 1987 Feb 15;36(4):453-6 - PubMed
  30. Environ Health Perspect. 1986 Dec;70:255-9 - PubMed
  31. Biol Reprod. 1987 Mar;36(2):277-81 - PubMed
  32. J Biol Chem. 1987 Oct 5;262(28):13534-7 - PubMed
  33. Proc Natl Acad Sci U S A. 1989 Jan;86(2):462-5 - PubMed
  34. Arch Biochem Biophys. 1989 Jan;268(1):144-51 - PubMed
  35. Experientia. 1989 Feb 15;45(2):174-5 - PubMed
  36. Mol Pharmacol. 1989 Mar;35(3):279-85 - PubMed
  37. Biochem Biophys Res Commun. 1989 Apr 28;160(2):609-14 - PubMed
  38. Cancer Res. 1989 Jun 15;49(12):3218-28 - PubMed
  39. J Biochem. 1989 Feb;105(2):161-3 - PubMed
  40. Arch Biochem Biophys. 1989 Jul;272(1):219-25 - PubMed
  41. Mol Pharmacol. 1989 Jul;36(1):97-105 - PubMed
  42. Mutat Res. 1989 Sep;227(1):53-8 - PubMed
  43. Arch Biochem Biophys. 1989 Nov 1;274(2):355-65 - PubMed
  44. Biochem Pharmacol. 1989 Oct 1;38(19):3147-55 - PubMed
  45. Int J Biochem. 1989;21(10):1103-7 - PubMed
  46. Br J Clin Pharmacol. 1989 Oct;28(4):373-87 - PubMed
  47. Cancer Res. 1990 May 1;50(9):2641-5 - PubMed
  48. Cancer Res. 1990 Jun 1;50(11):3367-76 - PubMed
  49. Mol Endocrinol. 1990 Mar;4(3):447-54 - PubMed
  50. Biochemistry. 1990 May 8;29(18):4430-3 - PubMed
  51. Drug Metab Rev. 1989-1990;21(3):427-61 - PubMed
  52. EMBO J. 1990 Sep;9(9):2835-42 - PubMed
  53. J Am Coll Cardiol. 1990 Nov;16(6):862-70 - PubMed
  54. Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1430-7 - PubMed
  55. DNA Cell Biol. 1991 Jan-Feb;10(1):1-14 - PubMed
  56. Drug Metab Dispos. 1990 Sep-Oct;18(5):595-606 - PubMed
  57. Cancer Res. 1992 Mar 1;52(5):1372-6 - PubMed
  58. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2145-9 - PubMed
  59. J Clin Endocrinol Metab. 1962 Mar;22:268-72 - PubMed
  60. J Endocrinol. 1965 Jul;32:287-93 - PubMed
  61. Arch Biochem Biophys. 1988 Jun;263(2):424-36 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources